I see a lot of whining about "PR clarity" of late; no real investors care whether the daytraders and flippers are dissatisfied with how the PPS action is. Management likely doesn't either. "Real companies" ignore rank amtuers with a few thousand shares that think they're the next Warren Buffet, so my email to Dr. Kelly will advise Cytodyn to do the same.